These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29631413)

  • 1. Nanotized PPARα Overexpression Targeted to Hypertrophied Myocardium Improves Cardiac Function by Attenuating the p53-GSK3β-Mediated Mitochondrial Death Pathway.
    Rana S; Datta R; Chaudhuri RD; Chatterjee E; Chawla-Sarkar M; Sarkar S
    Antioxid Redox Signal; 2019 Feb; 30(5):713-732. PubMed ID: 29631413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment.
    Ray A; Rana S; Banerjee D; Mitra A; Datta R; Naskar S; Sarkar S
    Toxicol Appl Pharmacol; 2016 Jan; 290():54-65. PubMed ID: 26612707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
    Banerjee D; Datta Chaudhuri R; Niyogi S; Roy Chowdhuri S; Poddar Sarkar M; Chatterjee R; Chakrabarti P; Sarkar S
    J Mol Cell Cardiol; 2020 Feb; 139():148-163. PubMed ID: 31958467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of telomere-associated repressor activator protein 1 precipitates cardiac aging in mice
    Cai Y; Liu H; Song E; Wang L; Xu J; He Y; Zhang D; Zhang L; Cheng KK; Jin L; Wu M; Liu S; Qi D; Zhang L; Lopaschuk GD; Wang S; Xu A; Xia Z
    Theranostics; 2021; 11(10):4710-4727. PubMed ID: 33754023
    [No Abstract]   [Full Text] [Related]  

  • 5. Arjunolic acid, a peroxisome proliferator-activated receptor α agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-β signaling.
    Bansal T; Chatterjee E; Singh J; Ray A; Kundu B; Thankamani V; Sengupta S; Sarkar S
    J Biol Chem; 2017 Oct; 292(40):16440-16462. PubMed ID: 28821620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
    Kar D; Bandyopadhyay A
    Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
    Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
    Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
    Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP
    Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-α expression induces alterations in cardiac myofilaments in a pressure-overload model of hypertrophy.
    Karam CN; Warren CM; Henze M; Banke NH; Lewandowski ED; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H681-H690. PubMed ID: 28130336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
    Planavila A; Iglesias R; Giralt M; Villarroya F
    Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
    Meng RS; Pei ZH; Yin R; Zhang CX; Chen BL; Zhang Y; Liu D; Xu AL; Dong YG
    Eur J Pharmacol; 2009 Oct; 620(1-3):63-70. PubMed ID: 19699196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].
    Shi HB; Shi HL; Zhang XY; Chen DX; Duan ZP; Ren F
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):211-216. PubMed ID: 28482409
    [No Abstract]   [Full Text] [Related]  

  • 13. PPAR signaling in the control of cardiac energy metabolism.
    Barger PM; Kelly DP
    Trends Cardiovasc Med; 2000 Aug; 10(6):238-45. PubMed ID: 11282301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A spatio-temporal cardiomyocyte targeted vector system for efficient delivery of therapeutic payloads to regress cardiac hypertrophy abating bystander effect.
    Rana S; Datta K; Reddy TL; Chatterjee E; Sen P; Pal-Bhadra M; Bhadra U; Pramanik A; Pramanik P; Chawla-Sarkar M; Sarkar S
    J Control Release; 2015 Feb; 200():167-78. PubMed ID: 25575863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cardiac Akt/protein kinase B signaling contributes to pathological cardiac hypertrophy in part by impairing mitochondrial function via transcriptional repression of mitochondrion-targeted nuclear genes.
    Wende AR; O'Neill BT; Bugger H; Riehle C; Tuinei J; Buchanan J; Tsushima K; Wang L; Caro P; Guo A; Sloan C; Kim BJ; Wang X; Pereira RO; McCrory MA; Nye BG; Benavides GA; Darley-Usmar VM; Shioi T; Weimer BC; Abel ED
    Mol Cell Biol; 2015 Mar; 35(5):831-46. PubMed ID: 25535334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes.
    Hou N; Luo MS; Liu SM; Zhang HN; Xiao Q; Sun P; Zhang GS; Luo JD; Chen MS
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1087-95. PubMed ID: 20738325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes.
    You J; Yue Z; Chen S; Chen Y; Lu X; Zhang X; Shen P; Li J; Han Q; Li Z; Liu P
    Acta Physiol (Oxf); 2017 May; 220(1):58-71. PubMed ID: 27614093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Pflugers Arch; 2007 Dec; 455(3):443-54. PubMed ID: 17643263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic analysis of PPARalpha-dependent alterations during cardiac hypertrophy.
    Smeets PJ; de Vogel-van den Bosch HM; Willemsen PH; Stassen AP; Ayoubi T; van der Vusse GJ; van Bilsen M
    Physiol Genomics; 2008 Dec; 36(1):15-23. PubMed ID: 18812456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart.
    Young ME; Laws FA; Goodwin GW; Taegtmeyer H
    J Biol Chem; 2001 Nov; 276(48):44390-5. PubMed ID: 11574533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.